Literature DB >> 28110125

Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.

Fei Pei1, Junjie Jiang1, Shuyun Bai1, Henghua Cao1, Luyang Tian1, Ya Zhao1, Chuanxiu Yang2, Haiheng Dong2, Yue Ma3.   

Abstract

Most existing culture media for cardiac differentiation of human pluripotent stem cells (hPSCs) contain significant amounts of albumin. For clinical transplantation applications of hPSC-derived cardiomyocytes (hPSC-CMs), culturing cells in an albumin containing environment raises the concern of pathogen contamination and immunogenicity to the recipient patients. In addition, batch-to-batch variation of albumin may cause the inconsistent of hPSC cardiac differentiation. Here, we demonstrated that antioxidants l-ascorbic acid, trolox, N-acetyl-l-cysteine (NAC) and sodium pyruvate could functionally substitute albumin in the culture medium, and formulated an albumin-free, chemical-defined medium (S12 medium). We showed that S12 medium could support efficient hPSC cardiac differentiation with significantly improved reproducibility, and maintained long-term culture of hPSC-CMs. Furthermore, under chemical-defined and albumin-free conditions, human-induced pluripotent stem cells (hiPSCs) were established, and differentiated into highly homogenous atrial and ventricular myocytes in a scalable fashion with normal electrophysiological properties. Finally, we characterized the activity of three typical cardiac ion channels of those cells, and demonstrated that hPSC-derived ventricular cardiomyocytes (hPSC-vCMs) were suitable for drug cardiac safety evaluation. In summary, this simplified, chemical-defined and albumin-free culture medium supports efficient generation and maintaining of hPSC-CMs and facilitates both research and clinical applications of these cells.
Copyright © 2017 Institute of Biophysics, Chinese Academy of Sciences. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Albumin; Antioxidants; Cardiac subtypes specification; Drugs; Human pluripotent stem cells (hPSCs)

Mesh:

Substances:

Year:  2017        PMID: 28110125     DOI: 10.1016/j.scr.2017.01.006

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  20 in total

1.  Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.

Authors:  Lukas Cyganek; Malte Tiburcy; Karolina Sekeres; Kathleen Gerstenberg; Hanibal Bohnenberger; Christof Lenz; Sarah Henze; Michael Stauske; Gabriela Salinas; Wolfram-Hubertus Zimmermann; Gerd Hasenfuss; Kaomei Guan
Journal:  JCI Insight       Date:  2018-06-21

2.  Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering.

Authors:  Bin Jiang; Li Yan; James G Shamul; Maxwell Hakun; Xiaoming He
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

Review 3.  Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.

Authors:  Liyuan Zhu; Kui Liu; Qi Feng; Yingnan Liao
Journal:  Stem Cell Rev Rep       Date:  2022-05-08       Impact factor: 5.739

4.  Human Atrial Cardiac Microtissues for Chamber-Specific Arrhythmic Risk Assessment.

Authors:  Arvin H Soepriatna; Tae Yun Kim; Mark C Daley; Elena Song; Bum-Rak Choi; Kareen L K Coulombe
Journal:  Cell Mol Bioeng       Date:  2021-09-29       Impact factor: 3.337

5.  Direct coculture of human pluripotent stem cell-derived cardiac progenitor cells with epicardial cells induces cardiomyocyte proliferation and reduces sarcomere organization.

Authors:  Martha E Floy; Kaitlin K Dunn; Taylor D Mateyka; Isabella M Reichardt; Alexandra B Steinberg; Sean P Palecek
Journal:  J Mol Cell Cardiol       Date:  2021-09-22       Impact factor: 5.000

6.  Structural and electrophysiological dysfunctions due to increased endoplasmic reticulum stress in a long-term pacing model using human induced pluripotent stem cell-derived ventricular cardiomyocytes.

Authors:  Chang Cui; Le Geng; Jiaojiao Shi; Yue Zhu; Gang Yang; Zidun Wang; Jiaxian Wang; Minglong Chen
Journal:  Stem Cell Res Ther       Date:  2017-05-11       Impact factor: 6.832

7.  Silencing of CCR4-NOT complex subunits affects heart structure and function.

Authors:  Lisa Elmén; Claudia B Volpato; Anaïs Kervadec; Santiago Pineda; Sreehari Kalvakuri; Nakissa N Alayari; Luisa Foco; Peter P Pramstaller; Karen Ocorr; Alessandra Rossini; Anthony Cammarato; Alexandre R Colas; Andrew A Hicks; Rolf Bodmer
Journal:  Dis Model Mech       Date:  2020-07-20       Impact factor: 5.758

8.  Single-Cell RNA Sequencing of Human Embryonic Stem Cell Differentiation Delineates Adverse Effects of Nicotine on Embryonic Development.

Authors:  Hongchao Guo; Lei Tian; Joe Z Zhang; Tomoya Kitani; David T Paik; Won Hee Lee; Joseph C Wu
Journal:  Stem Cell Reports       Date:  2019-02-28       Impact factor: 7.765

9.  Generation of spatial-patterned early-developing cardiac organoids using human pluripotent stem cells.

Authors:  Plansky Hoang; Jason Wang; Bruce R Conklin; Kevin E Healy; Zhen Ma
Journal:  Nat Protoc       Date:  2018-03-15       Impact factor: 13.491

Review 10.  A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.

Authors:  Pallavi Pushp; Diogo E S Nogueira; Carlos A V Rodrigues; Frederico C Ferreira; Joaquim M S Cabral; Mukesh Kumar Gupta
Journal:  Stem Cell Rev Rep       Date:  2020-10-23       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.